Atıf İçin Kopyala
ULUSOY S., ŞENKARDEŞ S., Coskun I., Bosgelmez-Tinaz G., Soulere L., Queneau Y., ...Daha Fazla
LETTERS IN DRUG DESIGN & DISCOVERY, cilt.14, sa.5, ss.613-618, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
14
Sayı:
5
-
Basım Tarihi:
2017
-
Doi Numarası:
10.2174/1570180814666161121120719
-
Dergi Adı:
LETTERS IN DRUG DESIGN & DISCOVERY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.613-618
-
Anahtar Kelimeler:
Celecoxib, sulfonylthioureido, 4-thiazolidinone, LasR protein, Pseudomonas aeruginosa, quorum sensing, BACTERIAL COMMUNICATION, INFECTIOUS-DISEASES, BIOFILM, DRUGS, IDENTIFICATION, VIRULENCE, MUTANT
-
Marmara Üniversitesi Adresli:
Evet
Özet
Background: A series of novel N-(substituted aryl/alkylcarbamothioyl)-4-[5-(4-methylphenyl)3-( trifluoromethyl)-1H-pyrazol-1-yl] benzene sulfonamides [SGK 318, 319, 320, 324, 327] and N-(3-substitutedaryl/ alkyl-4-oxo-1,3-thiazolidin-2-ylidene)-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamides[SGK 328, 329, 330, 334, 337] were synthesized and tested for their quorum sensing inhibitor (QSI) capacity using quorum sensing inhibitor selector 1 (QSIS1) bioassay.